Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,811 public trials 2,094 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Enrolling by Invitation

Supporting Sexual Recovery in Women With Bladder Cancer

NCT07091565

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +15 more
Locations: King's College, London London, United Kingdom

View Trial Details

Enrolling by Invitation

Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University Hospitals

NCT07088081

Conditions: Adenocarcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma, Carcinoma, +14 more
Locations: Ain Shams University Cairo, Abbasya, Egypt

View Trial Details

Enrolling by Invitation

The Efficacy of Sequential RT After Triple Therapy for uHCC

NCT07052448

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Fuzhou University Affiliated Provincial Hospital Fuzhou, Fujian, China

View Trial Details

Enrolling by Invitation

Clinical Evaluation of an Augmented Reality Intraprocedural Needle Guidance Platform for Soft Tissue Biopsy

NCT07046832

Conditions: Adenocarcinoma, Biopsy, Carcinoma, +23 more
Locations: MedStar Georgetown Hospital Washington D.C., District of Columbia, United States

MedStar Washington Hosptial Center Washington D.C., District of Columbia, United States

NewYork-Presbyterian Weill Cornell Medical Center New York, United States

View Trial Details

Enrolling by Invitation

AI-Driven Quantitative Decision and Surgical Planning System for Liver Cancer

NCT07042841

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Beijing Tsinghua Chang Gung Hospital Beijing, Beijing Municipality, China

View Trial Details

Enrolling by Invitation

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

NCT07023848

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +16 more
Locations: Affiliated Hospital of Jiangnan University Wuxi, Jiangsu, China

View Trial Details

Enrolling by Invitation

The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies

NCT07023861

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +16 more
Locations: Affiliated Hospital of Jiangnan University Wuxi, Jiangsu, China

View Trial Details

Enrolling by Invitation

Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy

NCT07016737

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Jiangsu Provincial Cancer Hospital Nanjing, Jiangsu, China

View Trial Details

Enrolling by Invitation

Adjuvant Immunotherapy Combined With ChemoRadiation for Patients With High-risk Resectable Extrahepatic Cholangiocarcinoma（AICRC）

NCT06997913

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +11 more
Locations: Department of Hepatobiliary Surgery, the First Affiliated Hospital of Air Force Military Medical University XiAn, Shanxi, China

View Trial Details

Enrolling by Invitation

Diagnostic Accuracy of Endocytoscopy for Superficial Esophageal Neoplasia

NCT06984055

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Changhai hosipital Shanghai, Shanghai Municipality, China

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions